Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 584 | 901 | 746 | 1,006 | 1,267 |
Gross Profit | 584 | 901 | 746 | 1,006 | 1,267 |
Operating Expenses | 4,029 | 5,691 | 2,348 | 2,260 | 2,207 |
Operating Income | -3,446 | -4,790 | -1,602 | -1,254 | -941 |
Interest Expense | 18 | 9 | 10 | 1 | 0 |
Other Income | 1 | 4 | -5 | 44 | -283 |
Pre-tax Income | -3,463 | -4,795 | -1,617 | -1,212 | -1,223 |
Income Tax | N/A | N/A | N/A | 15 | 15 |
Net Income Continuous | -3,448 | -4,795 | -1,617 | -1,227 | -1,238 |
Net Income | $-3,448 | $-4,795 | $-1,617 | $-1,227 | $-1,238 |
EPS Basic Total Ops | -15.02 | -21.32 | -7.51 | -6.01 | -3.00 |
EPS Basic Continuous Ops | -14.59 | -20.83 | -7.03 | -5.72 | -5.83 |
EPS Diluted Total Ops | -15.02 | -21.32 | -7.51 | -6.01 | -3.00 |
EPS Diluted Continuous Ops | -14.59 | -20.83 | -7.03 | -5.72 | -5.79 |
EBITDA(a) | $-3,418 | $-4,760 | $-1,561 | $-1,217 | $-908 |